Volkow ND. Stigma and the toll of addiction. N Engl J Med. 2020;382(14):1289-1290. https://doi.org/10.1056/NEJMp1917360

Article  PubMed  Google Scholar 

Perry BL, Pescosolido BA, Krendl AC. The unique nature of public stigma toward non-medical prescription opioid use and dependence: a national study. Addiction. 2020;115(12):2317-2326. https://doi.org/10.1111/add.15069

Article  PubMed  Google Scholar 

Pescosolido BA, Martin JK, Long JS, Medina TR, Phelan JC, Link BG. “A disease like any other”? A decade of change in public reactions to schizophrenia, depression, and alcohol dependence. Am J Psychiatry. 2010;167(11):1321-1330. https://doi.org/10.1176/appi.ajp.2010.09121743

Article  PubMed  PubMed Central  Google Scholar 

Ciccarone D. The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis. Curr Opin Psychiatry. 2021;34(4):344-350. https://doi.org/10.1097/YCO.0000000000000717

Article  PubMed  PubMed Central  Google Scholar 

Kennedy-Hendricks A, Barry CL, Gollust SE, Ensminger ME, Chisolm MS, McGinty EE. Social stigma toward persons with prescription opioid use disorder: associations with public support for punitive and public health-oriented policies. Psychiatr Serv Wash DC. 2017;68(5):462-469. https://doi.org/10.1176/appi.ps.201600056

Article  Google Scholar 

Harocopos A, Gibson BE, Saha N, et al. First 2 months of operation at first publicly recognized overdose prevention centers in US. JAMA Netw Open. 2022;5(7):e2222149. https://doi.org/10.1001/jamanetworkopen.2022.22149

Article  PubMed  PubMed Central  Google Scholar 

Ivsins A, Boyd J, Beletsky L, McNeil R. Tackling the overdose crisis: the role of safe supply. Int J Drug Policy. 2020;80:102769. https://doi.org/10.1016/j.drugpo.2020.102769

Article  PubMed  PubMed Central  Google Scholar 

U.S. Department of Health and Human Services (HHS), Office of the Surgeon General. Facing Addiction in America: The Surgeon General’s Spotlight on Opioids. HHS; 2018. https://addiction.surgeongeneral.gov/sites/default/files/Spotlight-on-Opioids_09192018.pdf

American Society of Addiction Medicine. Public policy statement: definition of addiction 2019. Published September 15, 2019. Accessed October 2, 2020. https://www.asam.org/Quality-Science/definition-of-addiction

Volkow ND, Koob GF, McLellan AT. Neurobiologic advances from the brain disease model of addiction. N Engl J Med. 2016;374(4):363-371. https://doi.org/10.1056/NEJMra1511480

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kelly JF, Greene MC, Abry A. A US national randomized study to guide how best to reduce stigma when describing drug-related impairment in practice and policy. Addiction. 2021;116(7):1757-1767. https://doi.org/10.1111/add.15333

Article  PubMed  Google Scholar 

Kvaale EP, Haslam N, Gottdiener WH. The ‘Side Effects’ of medicalization: a meta-analytic review of how biogenetic explanations affect stigma. Clin Psychol Rev. 2013;33(6):782-794. https://doi.org/10.1016/j.cpr.2013.06.002

Article  PubMed  Google Scholar 

Phelan JC. Geneticization of deviant behavior and consequences for stigma: the case of mental illness. J Health Soc Behav. 2005;46(4):307-322. https://doi.org/10.1177/002214650504600401

Article  PubMed  Google Scholar 

Pytell JD, Sklar MD, Carrese J, Rastegar DA, Gunn C, Chander G. “I’m a survivor”: perceptions of chronic disease and survivorship among individuals in long-term remission from opioid use disorder. J Gen Intern Med. 2022;37(3):593-600. https://doi.org/10.1007/s11606-021-06925-z

Article  PubMed  Google Scholar 

Shapiro CL. Cancer survivorship. N Engl J Med. 2018;379(25):2438-2450. https://doi.org/10.1056/NEJMra1712502

Article  PubMed  Google Scholar 

Netherland J, Hansen HB. The war on drugs that wasn’t: wasted whiteness, “dirty doctors,” and race in media coverage of prescription opioid misuse. Cult Med Psychiatry. 2016;40(4):664-686. https://doi.org/10.1007/s11013-016-9496-5

Article  PubMed  PubMed Central  Google Scholar 

Mendoza S, Rivera AS, Hansen HB. Re-racialization of addiction and the redistribution of blame in the white opioid epidemic. Med Anthropol Q. 2019;33(2):242-262. https://doi.org/10.1111/maq.12449

Article  PubMed  Google Scholar 

Hansen H, Netherland J. Is the prescription opioid epidemic a white problem? Am J Public Health. 2016;106(12):2127-2129. https://doi.org/10.2105/AJPH.2016.303483

Article  PubMed  PubMed Central  Google Scholar 

Andraka-Christou B. Addressing racial and ethnic disparities in the use of medications for opioid use disorder. Health Aff (Millwood). 2021;40(6):920-927. https://doi.org/10.1377/hlthaff.2020.02261

Article  PubMed  Google Scholar 

Lagisetty PA, Ross R, Bohnert A, Clay M, Maust DT. Buprenorphine treatment divide by race/ethnicity and payment. JAMA Psychiatry. 2019;76(9):979-981. https://doi.org/10.1001/jamapsychiatry.2019.0876

Article  PubMed  PubMed Central  Google Scholar 

Alexander M, West C. The New Jim Crow: Mass Incarceration in the Age of Colorblindness. Revised edition. New Press; 2012.

Stein BD, Dick AW, Sorbero M, et al. A population-based examination of trends and disparities in medication treatment for opioid use disorders among medicaid enrollees. Subst Abuse. 2018;39(4):419-425. https://doi.org/10.1080/08897077.2018.1449166

Article  Google Scholar 

Hansen H, Roberts SK. Two tiers of biomedicalization: methadone, buprenorphine, and the racial politics of addiction treatment. In: Netherland J, ed. Advances in Medical Sociology. Emerald Group Publishing Limited; 2012:79-102. https://doi.org/10.1108/S1057-6290(2012)0000014008

Kulesza M, Matsuda M, Ramirez JJ, Werntz AJ, Teachman BA, Lindgren KP. Towards greater understanding of addiction stigma: intersectionality with race/ethnicity and gender. Drug Alcohol Depend. 2016;169:85-91. https://doi.org/10.1016/j.drugalcdep.2016.10.020

Article  PubMed  PubMed Central  Google Scholar 

Wirth JH, Bodenhausen GV. The role of gender in mental-illness stigma: a national experiment. Psychol Sci. 2009;20(2):169-173. https://doi.org/10.1111/j.1467-9280.2009.02282.x

Article  PubMed  Google Scholar 

Terplan M, Kennedy-Hendricks A, Chisolm MS. Prenatal substance use: exploring assumptions of maternal unfitness. Subst Abuse Res Treat. 2015;9(Suppl 2):1-4. https://doi.org/10.4137/SART.S23328

Article  Google Scholar 

Harris MTH, Laks J, Stahl N, Bagley SM, Saia K, Wechsberg WM. Gender dynamics in substance use and treatment: a women’s focused approach. Med Clin North Am. 2022;106(1):219-234. https://doi.org/10.1016/j.mcna.2021.08.007

Article  PubMed  Google Scholar 

McGinty EE. Portraying mental illness and drug addiction as treatable health conditions: effects of a randomized experiment on stigma and discrimination. Soc Sci. Published online 2015:13.

Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95(May). https://doi.org/10.1016/j.jbi.2019.103208

Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377-381. https://doi.org/10.1016/j.jbi.2008.08.010

Article  PubMed  Google Scholar 

Ma DS, Correll J, Wittenbrink B. The Chicago face database: a free stimulus set of faces and norming data. Behav Res Methods. 2015;47(4):1122-1135. https://doi.org/10.3758/s13428-014-0532-5

Article  PubMed  Google Scholar 

ASAM Definition of Addiction. Accessed January 21, 2021. https://www.asam.org/Quality-Science/definition-of-addiction

Heilig M, MacKillop J, Martinez D, Rehm J, Leggio L, Vanderschuren LJMJ. Addiction as a brain disease revised: why it still matters, and the need for consilience. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol. 2021;46(10):1715-1723. https://doi.org/10.1038/s41386-020-00950-y

Article  Google Scholar 

Lopez-Quintero C, Hasin DS, de Los Cobos JP, et al. Probability and predictors of remission from life-time nicotine, alcohol, cannabis or cocaine dependence: results from the national epidemiologic survey on alcohol and related conditions. Addict Abingdon Engl. 2011;106(3):657-669. https://doi.org/10.1111/j.1360-0443.2010.03194.x

Article  Google Scholar 

Robins LN, Davis DH, Nurco DN. How permanent was Vietnam drug addiction? Am J Public Health. 1974;64 Suppl 12:38-43. https://doi.org/10.2105/ajph.64.12_suppl.38

Article  PubMed  PubMed Central  Google Scholar 

Hagman BT, Falk D, Litten R, Koob GF. Defining recovery from alcohol use disorder: development of an NIAAA research definition. Am J Psychiatry. Published online April 12, 2022:appi.ajp.21090963. https://doi.org/10.1176/appi.ajp.21090963

Leeper T. margins: Marginal Effects for Model Objects. Published online 2021.

R Core Team. R: a language and environment for statistical computing. Published online 2021.

Rogers CR. The necessary and sufficient conditions of therapeutic personality change. J Consult Psychol. 1957;21(2):95-103. https://doi.org/10.1037/h0045357

Article  CAS  PubMed  Google Scholar 

Miller WR, Rollnick S. Motivational Interviewing: Helping People Change. 3rd ed. Guilford Press; 2013.

Schiff DM, Stoltman JJK, Nielsen TC, et al. Assessing stigma towards substance use in pregnancy: a randomized study testing the impact of stigmatizing language and type of opioid use on attitudes toward mothers with opioid use disorder. J Addict Med. 2022;16(1):77-83. https://doi.org/10.1097/ADM.0000000000000832

Article  PubMed  Google Scholar 

Lie AK, Hansen H, Herzberg D, et al. The harms of constructing addiction as a chronic, relapsing brain disease. Am J Public Health. 2022;112(S2):S104-S108. https://doi.org/10.2105/AJPH.2021.306645

Article  PubMed  Google Scholar 

McGinty EE, Barry CL, Stone EM, et al. Public support for safe consumption sites and syringe services programs to combat the opioid epidemic. Prev Med. 2018;111:73-77. https://doi.org/10.1016/j.ypmed.2018.02.026

Article  PubMed  Google Scholar 

McGinty EE, Stone EM, Kennedy-Hendricks A, Bachhuber MA, Barry CL. Medication for opioid use disorder: a national survey of primary care physicians. Ann Intern Med. 2020;173(2):160-162. https://doi.org/10.7326/M19-3975

Article  PubMed  PubMed Central  Google Scholar 

Calcaterra SL, Bach P, Chadi A, et al. Methadone matters: what the United States can learn from the global effort to treat opioid addiction. J Gen Intern Med. 2019;34(6):1039-1042. https://doi.org/10.1007/s11606-018-4801-3

Article  CAS  PubMed  PubMed Central  Google Scholar